The Research On The Financial Early Warning Of The Pharmaceutical Industrylisting Corporation

As the pharmaceutical industry is growing rapidly, many pharmaceutical listing Corporation have already focused on the financial situation of the enterprise as the focus of the monitoring object. Because once the financial crisis of the listing Corporation, not only seriously affect the normal operation of the enterprise, but also may bring losses to investors. The pharmaceutical industry as a knowledge intensive, high technology content, multidisciplinary comprehensive high degree of integration of industry, in the entire production and sales process will face a complex financial risk and market risk, and our country currently our financial early warning system for analysis in the study of all listed companies, and there is no specific analysis for the pharmaceutical industry, financial risk, so it is an urgent need for people to enhance understanding of financial early warning system of pharmaceutical industry listed companies.Although at this stage pharmaceutical industry overall development situation is good, but there are also many financial problems can not be ignored, which affects the development of the company, the operation of Listed Companies in the pharmaceutical industry and the financial problems still have potential crisis. Therefore, the establishment of suitable for their own development financial early warning system of Listed Companies in the pharmaceutical industry health development has a profound impact, and can effectively reduce the pharmaceutical industry listed company financial problems of probabilitye.Through the use of cash flow, financial performance, growth ability, choose the corresponding financial strategy that several index system of financial indicators for the pharmaceutical industry listed company financial risk problems are analyzed. In addition, in the light of the characteristics of the pharmaceutical industry listed companies, adopt a quantitative approach and will pick out the appropriate financial ratios and p, the listed companies in the pharmaceutical industry is a top priority in the financial early warning index system of selecting; Adopt a qualitative approach and clear company which stage in the growth cycle, and then a more comprehensive focus determine the company’s financial risk problems, establish and improve the suitable for pharmaceutical industry listed company financial warning system. In view of the Chinese pharmaceutical industry has the particularity, as the pharmaceutical industry listed companies through choosing YNBY company of the most representative of a company, the author analyzes the characteristic of YNBY company, build suitable for YNBY company financial early warning index system, using the combination of qualitative quantitative method can accurately determine the possibility of the enterprise financial risk in the future, thereby, including for YNBY company, China’s pharmaceutical industry listed companies to establish a more targeted financial early-warning index system.